Echocardiographic score for the screening of cardiac amyloidosis with positive 99m technetium pyrophosphate scintigraphy result
Echocardiography · 2023
DOI: 10.1111/echo.15626 ↗At a glance
Journal article in Echocardiography, 2023. Written by Tomoo Nagai and 6 co-authors. Institution: Division of Cardiology, Department of Internal Medicine, Tokai University School of Medicine, Kanagawa, Japan. Major MEDLINE topics: Amyloidosis, Cardiomyopathies. Cited 5 times so far (Crossref); 41 references.
Abstract (original language)
Introduction
Speckle‐tracking‐derived strains in cardiac chambers may provide better solutions for transthyretin amyloid cardiomyopathy (ATTR‐CM) screening. This study aimed to evaluate the efficacy of biventricular strain measurements using speckle tracking for screening 99m Tc‐pyrophosphate ( 99m Tc‐PYP) scintigraphy‐positive cardiomyopathy, which is nearly equivalent to ATTR‐CM.
Methods
We performed a retrospective analysis of transthoracic echocardiographic studies using vendor‐independent speckle tracking analysis in older patients (≥65 years) who underwent 99m Tc‐PYP scintigraphy to evaluate the etiology of suspected ATTR‐CM in our institute between January 2019 and December 2022.
Results
The entire cohort ( n = 89) was divided into two subgroups positive 99m Tc‐PYP scan results ( n = 34) and negative 99m Tc‐PYP scan results ( n = 55). In the multivariate analysis, posterior wall thickness ( p = .003, odds ratio [OR]:1.48, 95% confidence interval [CI]:1.14 –1.92), left ventricular longitudinal strain apical/basal ratio (LVLSapi/bas) ( p = .015, OR: 2.78, 95% CI: 1.23–6.32, and right ventricular longitudinal strain (RVLS) ( p = .003, OR: 1.15, 95% CI: 1.05 –1.26) were selected to be the most representative echocardiographic findings in 99m Tc‐PYP positive cardiomyopathy. The receiver operating characteristic analysis indicated that posterior wall thickness ( p < .0001, area under the curve [AUC]: .821, cut‐off value: 14.0 mm), LVLSapi/bas ( p < .001, AUC: .802, cut‐off value: 2,16), and RVLS ( p < .001, AUC: .791, cut‐off value: ‐18.7%) could significantly detect 99m Tc‐PYP positive results with an excellent credibility. Echocardiographic score points calculated using the summary of these three parameters in each patient revealed that a 2‐point score had a fair sensitivity (85%) and an excellent specificity (93%), while a 1‐point score had an excellent sensitivity (91%) and a modest specificity (53%).
Conclusion
Our proposed echocardiographic screening tool for 99m Tc‐PYP scintigraphy‐positive cardiomyopathy may help clinicians manage patients with suspected ATTR‐CM.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Division of Cardiology, Department of Internal Medicine, Tokai University School of Medicine, Kanagawa, Japan.
- Department of Diagnostic Radiology, Tokai University School of Medicine, Kanagawa, Japan.
Cite
APA
Nagai, T., Horinouchi, H., Hashimoto, K., Ichiji, T., Yoshioka, K., Hashimoto, J., & Ikari, Y. (2023). Echocardiographic score for the screening of cardiac amyloidosis with positive 99m technetium pyrophosphate scintigraphy result. Echocardiography. https://doi.org/10.1111/echo.15626
Vancouver
Nagai T, Horinouchi H, Hashimoto K, Ichiji T, Yoshioka K, Hashimoto J, et al. Echocardiographic score for the screening of cardiac amyloidosis with positive 99m technetium pyrophosphate scintigraphy result. Echocardiography. 2023. doi:10.1111/echo.15626
BibTeX
@article{Nagai2023,
author = {Nagai, Tomoo and Horinouchi, Hitomi and Hashimoto, Kaho and Ichiji, Takeshi and Yoshioka, Koichiro and Hashimoto, Jun and Ikari, Yuji},
title = {Echocardiographic score for the screening of cardiac amyloidosis with positive 99m technetium pyrophosphate scintigraphy result},
journal = {Echocardiography},
year = {2023},
doi = {10.1111/echo.15626}
}
EUVIMED